1 |
(2)-epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
008 1件: 8 💬 |
2 |
20 mg ga |
- |
- |
- |
- |
013 1件: 13 💬 |
3 |
20mg/0.5ml ga |
- |
- |
- |
- |
013 1件: 13 💬 |
4 |
40 mg ga |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
5 |
Aav1-gamma-sarcoglycan vector injection |
- |
- |
- |
- |
113 1件: 113 💬 |
6 |
Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase a cdna |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
7 |
Administration of drug (interferon-gamma 1-b) subcutaneously |
- |
- |
- |
- |
065 1件: 65 💬 |
8 |
Adverse reactions of gammagard subcutaneously at week 12 |
- |
- |
- |
- |
065 1件: 65 💬 |
9 |
Adverse reactions of gammagard subcutaneously at week 24 |
- |
- |
- |
- |
065 1件: 65 💬 |
10 |
Adverse reactions of gammagard subcutaneously at week 36 |
- |
- |
- |
- |
065 1件: 65 💬 |
11 |
Adverse reactions of gammagard subdermally at week 12 |
- |
- |
- |
- |
065 1件: 65 💬 |
12 |
Adverse reactions of gammagard subdermally at week 24 |
- |
- |
- |
- |
065 1件: 65 💬 |
13 |
Adverse reactions of gammagard subdermally at week 36 |
- |
- |
- |
- |
065 1件: 65 💬 |
14 |
Aerosol interferon-gamma |
- |
- |
- |
- |
085 1件: 85 💬 |
15 |
Aert, (r)-baclofen |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
16 |
Alpha-galactosidase a |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
17 |
Analysis of gamma globulin |
- |
- |
- |
- |
084 1件: 84 💬 |
18 |
Anti-interferon-gamma monoclonal antibody |
- |
- |
- |
- |
096 1件: 96 💬 |
19 |
Anti-pseudomonas igy gargle |
- |
- |
- |
- |
299 1件: 299 💬 |
20 |
Antithymocyte gamma immunoglobulin |
- |
- |
- |
- |
013 1件: 13 💬 |
21 |
Baclofen |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
002 5件: 2 , 10, 13, 18, 149 💬 |
22 |
Baclofen 20 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
23 |
Baclofen er capsules (grs) 10 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
24 |
Baclofen er capsules (grs) 20 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
25 |
Baclofen er capsules (grs) 30mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
26 |
Baclofen er capsules (grs) 40mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
27 |
Baclofen er capsules (grs) 50 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
28 |
Baclofen ir |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
29 |
Baclofen tablets usp |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
30 |
Baclofen tablets usp 10 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
31 |
Behavioral: gait and balance |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
32 |
Behavioral: gait and balance training program |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
33 |
Bitterschleifenblume-ganzpflanze 1,5ml/10ml |
- |
- |
- |
- |
097 1件: 97 💬 |
34 |
Boots high strength garlic odour controlled |
Garlic |
- |
- |
- |
299 1件: 299 💬 |
35 |
Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
070 1件: 70 💬 |
36 |
Budenofalk 3mg gastro-resistant capsules |
- |
- |
- |
- |
096 1件: 96 💬 |
37 |
Budenofalk 9mg gastro-resistant granules |
- |
- |
- |
- |
096 1件: 96 💬 |
38 |
Coconut oil and epigallocatechin gallate |
Coconut |
1件: D05326 D05326 💬 |
- |
- |
013 1件: 13 💬 |
39 |
D-galactose |
Galactose |
1件: D04291 D04291 💬 |
- |
- |
222 1件: 222 💬 |
40 |
Device: chrono super pid then generic syringe-gammanorm |
- |
- |
- |
- |
065 1件: 65 💬 |
41 |
Device: cotton gauze with petrolatum |
Cotton |
2件: D05304 D05304, D05331 D05331 💬 |
- |
- |
035 2件: 35, 162 💬 |
42 |
Device: generic syringe then chrono super pid-gammanorm |
- |
- |
- |
- |
065 1件: 65 💬 |
43 |
Device: magnetic resonance imaging (mri) with gadolinium enhancement |
Gadolinium |
- |
- |
- |
058 1件: 58 💬 |
44 |
Device: magnetic resonance imaging (mri) without gadolinium enhancement |
Gadolinium |
- |
- |
- |
058 1件: 58 💬 |
45 |
Device: percutaneous endoscopic gastrostomy tube |
- |
- |
- |
- |
006 1件: 6 💬 |
46 |
Device: percutaneous endoscopic gastrostomy tube (peg tube) |
- |
- |
- |
- |
006 1件: 6 💬 |
47 |
Device: video game therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
48 |
Diagnostic test: 68-ga ha-dotatate pet/ct |
Dotatate |
- |
- |
- |
041 1件: 41 💬 |
49 |
Diagnostic test: cardiac mri (gadolinium enhanced) |
Gadolinium |
- |
- |
- |
086 1件: 86 💬 |
50 |
Diagnostic test: gait analysis |
- |
- |
- |
- |
149 1件: 149 💬 |
51 |
Efficacy of gammagard subcutaneously at week 12 |
- |
- |
- |
- |
065 1件: 65 💬 |
52 |
Efficacy of gammagard subcutaneously at week 24 |
- |
- |
- |
- |
065 1件: 65 💬 |
53 |
Efficacy of gammagard subcutaneously at week 36 |
- |
- |
- |
- |
065 1件: 65 💬 |
54 |
Efficacy of gammagard subdermally at week 12 |
- |
- |
- |
- |
065 1件: 65 💬 |
55 |
Efficacy of gammagard subdermally at week 24 |
- |
- |
- |
- |
065 1件: 65 💬 |
56 |
Efficacy of gammagard subdermally at week 36 |
- |
- |
- |
- |
065 1件: 65 💬 |
57 |
Emapalumab |
Emapalumab |
1件: D11120 D11120 💬 |
IFNG 1件: IFNG 💬 |
African trypanosomiasis 32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
107 1件: 107 💬 |
58 |
Encapsulated baclofen 20 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
59 |
Epigallocatechin gallate |
Epigallocatechin |
- |
- |
- |
013 1件: 13 💬 |
60 |
Epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
028 2件: 28, 85 💬 |
61 |
Epigallocatechin-gallate |
Epigallocatechin |
- |
- |
- |
113 1件: 113 💬 |
62 |
Epigallocatechin-gallate (sunphenon) |
Epigallocatechin |
- |
- |
- |
013 1件: 13 💬 |
63 |
Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length lamb3 cdna. |
- |
- |
- |
- |
036 1件: 36 💬 |
64 |
Firategrast gastro-retentive solution |
Firategrast |
1件: D06590 D06590 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
65 |
Fish oil, gamma-linolenic acid |
Fish oil |
1件: D07213 D07213 💬 |
- |
- |
046 1件: 46 💬 |
66 |
Fully human anti-interferon gamma monoclonal antibody |
Interferon Gamma |
- |
- |
- |
107 1件: 107 💬 |
67 |
Ga |
- |
- |
- |
- |
013 1件: 13 💬 |
68 |
Ga 20 mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
69 |
Ga 40 mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
70 |
Ga depot |
- |
- |
- |
- |
013 1件: 13 💬 |
71 |
Ga depot 40 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
72 |
Ga depot 40mg once monthly |
- |
- |
- |
- |
013 1件: 13 💬 |
73 |
Ga depot 80 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
74 |
Ga-68-dota-noc |
- |
- |
- |
- |
084 1件: 84 💬 |
75 |
Ga-gcb |
Velaglucerase alfa |
1件: D09029 D09029 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
76 |
Ga-gcb (velaglucerase alfa) |
Velaglucerase alfa |
1件: D09029 D09029 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
77 |
Gabapentin |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 5件: 6 , 13, 19, 70, 298 💬 |
78 |
Gabapentin prescriptions |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
298 1件: 298 💬 |
79 |
Gabapentina |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 1件: 6 💬 |
80 |
Gabapentina kern pharma |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 1件: 6 💬 |
81 |
Gabapentine |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
013 1件: 13 💬 |
82 |
Gabapentine 300mg |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
013 1件: 13 💬 |
83 |
Gaboxadol |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 2件: 201, 206 💬 |
84 |
Gaboxadol monohydrate |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
85 |
Gaboxadol monohydrate 0.5 mg |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
86 |
Gaboxadol monohydrate 0.5 mg (intended commercial formulation) |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
87 |
Gaboxadol monohydrate 0.5 mg capsule |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
88 |
Gaboxadol monohydrate 2 mg |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
89 |
Gaboxadol monohydrate 2 mg (intended commercial formulation) |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
90 |
Gaboxadol monohydrate 2 mg capsule |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
91 |
Gaboxadol monohydrate 5 mg |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
92 |
Gaboxadol monohydrate 5 mg (intended commercial formulation) |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
93 |
Gadobenate |
Gadobenic acid |
2件: D04283 D04283, D08018 D08018 💬 |
- |
- |
013 1件: 13 💬 |
94 |
Gadobenate dimeglumine |
Gadobenic acid |
2件: D04283 D04283, D08018 D08018 💬 |
- |
- |
013 1件: 13 💬 |
95 |
Gadobutrol |
Gadobutrol |
1件: D07420 D07420 💬 |
- |
- |
013 3件: 13, 22, 46 💬 |
96 |
Gadodiamide |
Gadodiamide |
2件: D01645 D01645, D04284 D04284 💬 |
- |
- |
305 1件: 305 💬 |
97 |
Gadolinium |
Gadolinium |
- |
- |
- |
013 6件: 13, 34, 46, 58, 65, 86 💬 |
98 |
Gadolinium contrast |
Gadolinium |
- |
- |
- |
034 1件: 34 💬 |
99 |
Gadolinium for abdomen |
Gadolinium |
- |
- |
- |
065 1件: 65 💬 |
100 |
Gadolinium for lower back |
Gadolinium |
- |
- |
- |
065 1件: 65 💬 |
101 |
Gadolinium-based contrast |
Gadolinium |
- |
- |
- |
013 1件: 13 💬 |
102 |
Gadopentetate |
Gadopentetic acid |
2件: D01707 D01707, D08006 D08006 💬 |
- |
- |
013 2件: 13, 34 💬 |
103 |
Gadoterate |
Gadoteric acid |
1件: D08007 D08007 💬 |
- |
- |
053 1件: 53 💬 |
104 |
Gadoteric acid |
Gadoteric acid |
1件: D08007 D08007 💬 |
- |
- |
013 1件: 13 💬 |
105 |
Gadoteridol |
Gadoteridol |
1件: D01137 D01137 💬 |
- |
- |
013 1件: 13 💬 |
106 |
Gadovist |
- |
- |
- |
- |
013 2件: 13, 22 💬 |
107 |
Gadovist 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado |
- |
- |
- |
- |
013 1件: 13 💬 |
108 |
Gadovist 1.0 mmol/ml injektionslösung |
- |
- |
- |
- |
013 1件: 13 💬 |
109 |
Galactose |
Galactose |
1件: D04291 D04291 💬 |
- |
- |
171 2件: 171, 222 💬 |
110 |
Galafold |
- |
- |
- |
- |
019 1件: 19 💬 |
111 |
Galantamine |
Galantamine |
2件: D02173 D02173, D04292 D04292 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
006 2件: 6 , 127 💬 |
112 |
Galantamine hydrobromide |
Galantamine |
2件: D02173 D02173, D04292 D04292 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
127 1件: 127 💬 |
113 |
Galen® tablet |
- |
- |
- |
- |
043 2件: 43, 44 💬 |
114 |
Galicaftor |
Galicaftor |
1件: D11724 D11724 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
115 |
Gallium nitrate |
Gallium nitrate |
2件: D00940 D00940, D02313 D02313 💬 |
- |
- |
299 1件: 299 💬 |
116 |
Gallium-68 dotatate |
Dotatate |
- |
- |
- |
084 1件: 84 💬 |
117 |
Gallium-68-dota-n-octreotide |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 1件: 84 💬 |
118 |
Gallium68-dota-noc |
- |
- |
- |
- |
085 1件: 85 💬 |
119 |
Galsulfase |
Galsulfase |
1件: D06565 D06565 💬 |
ARSB 1件: ARSB 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |
120 |
Gamma globulin |
- |
- |
- |
- |
015 2件: 15, 50 💬 |
121 |
Gamma interferon |
- |
- |
- |
- |
018 1件: 18 💬 |
122 |
Gamma-linolenic acid |
Gamolenic acid |
1件: D07213 D07213 💬 |
- |
- |
046 1件: 46 💬 |
123 |
Gamma-secretase/notch signalling pathway inhibitor ro4929097 |
- |
- |
- |
- |
074 1件: 74 💬 |
124 |
Gamma-tocopherol |
Tocopherol |
1件: D02332 D02332 💬 |
- |
- |
013 1件: 13 💬 |
125 |
Gammagard liquid |
- |
- |
- |
- |
065 1件: 65 💬 |
126 |
Gammagard s/d (solvent/detergent) |
- |
- |
- |
- |
065 1件: 65 💬 |
127 |
Gammaglobulin |
- |
- |
- |
- |
065 1件: 65 💬 |
128 |
Gammanorm |
- |
- |
- |
- |
014 2件: 14, 65 💬 |
129 |
Gammanorm 165 mg/ml |
- |
- |
- |
- |
065 1件: 65 💬 |
130 |
Gammaplex |
- |
- |
- |
- |
063 2件: 63, 65 💬 |
131 |
Gammaplex (5%) |
- |
- |
- |
- |
065 1件: 65 💬 |
132 |
Gammaplex (intravenous immunoglobulin) |
- |
- |
- |
- |
065 1件: 65 💬 |
133 |
Gammaplex 10 |
- |
- |
- |
- |
065 1件: 65 💬 |
134 |
Gammaplex, intravenous immunoglobulin |
- |
- |
- |
- |
063 1件: 63 💬 |
135 |
Gamunex 10% |
- |
- |
- |
- |
011 1件: 11 💬 |
136 |
Gamunex-c |
- |
- |
- |
- |
065 1件: 65 💬 |
137 |
Ganaxolone |
Ganaxolone |
1件: D04300 D04300 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
145 4件: 145, 152, 158, 206 💬 |
138 |
Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one) |
Ganaxolone |
1件: D04300 D04300 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
152 1件: 152 💬 |
139 |
Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one) |
Ganaxolone |
1件: D04300 D04300 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
152 1件: 152 💬 |
140 |
Ganciclovir |
Ganciclovir |
2件: D00333 D00333, D04301 D04301 💬 |
- |
- |
028 3件: 28, 60, 97 💬 |
141 |
Ganoderma |
- |
- |
- |
- |
006 1件: 6 💬 |
142 |
Gardasil |
- |
- |
- |
- |
049 1件: 49 💬 |
143 |
Garetosmab |
Garetosmab |
1件: D11443 D11443 💬 |
- |
- |
272 1件: 272 💬 |
144 |
Garlic |
Garlic |
- |
- |
- |
299 1件: 299 💬 |
145 |
Gastro-resistant phosphatidylcholine granules |
Lecithin |
1件: D04682 D04682 💬 |
- |
- |
097 1件: 97 💬 |
146 |
Gastrus |
- |
- |
- |
- |
066 1件: 66 💬 |
147 |
Gentamicin |
Gentamicin |
2件: D01063 D01063, D08013 D08013 💬 |
- |
- |
036 3件: 36, 113, 299 💬 |
148 |
Gentamicin infusions twice a week for six months |
Gentamicin |
2件: D01063 D01063, D08013 D08013 💬 |
- |
- |
113 1件: 113 💬 |
149 |
Gentamicin sulfate |
Gentamicin |
2件: D01063 D01063, D08013 D08013 💬 |
- |
- |
036 1件: 36 💬 |
150 |
Gentamicin sulfate 0.1% ointment |
Gentamicin |
2件: D01063 D01063, D08013 D08013 💬 |
- |
- |
036 1件: 36 💬 |
151 |
Gentamicin sulfate, injectable |
Gentamicin |
2件: D01063 D01063, D08013 D08013 💬 |
- |
- |
036 1件: 36 💬 |
152 |
Glatiramer acetate (ga) |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
153 |
Glatiramer acetate (ga) 40 mg |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
154 |
Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
155 |
Glatiramer acetate [ga] |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
156 |
Gm1 ganglioside |
- |
- |
- |
- |
006 1件: 6 💬 |
157 |
Helium / oxygen mixed gas inhalation therapy |
Helium |
2件: D00003 D00003, D04420 D04420 💬 |
- |
- |
330 1件: 330 💬 |
158 |
Hpv prophylactic vaccine gardasil |
- |
- |
- |
- |
049 1件: 49 💬 |
159 |
Human papillomavirus vaccination (gardasil) |
- |
- |
- |
- |
049 1件: 49 💬 |
160 |
Human soluble recombinant fc-gamma receptor iib |
- |
- |
- |
- |
066 1件: 66 💬 |
161 |
Humanized immunoglobulin gamma 1 (igg1) kappa monoclonal antibody |
- |
- |
- |
- |
046 1件: 46 💬 |
162 |
Hyperpolarized 129 xenon gas comparing idiopathic pulmonary fibrosis (ipf) treatment |
Xenon |
2件: D01901 D01901, D06339 D06339 💬 |
- |
- |
085 1件: 85 💬 |
163 |
Hyperpolarized 129-xenon gas |
Xenon |
2件: D01901 D01901, D06339 D06339 💬 |
- |
- |
085 1件: 85 💬 |
164 |
Hyperpolarized xenon gas |
Xenon |
2件: D01901 D01901, D06339 D06339 💬 |
- |
- |
299 1件: 299 💬 |
165 |
Ifn-gamma |
- |
- |
- |
- |
065 1件: 65 💬 |
166 |
Inomax 400ppm mol/mol inhalation gas |
- |
- |
- |
- |
085 2件: 85, 299 💬 |
167 |
Interferon gamma |
Interferon Gamma |
- |
- |
- |
018 8件: 18, 65, 85, 107, 228, 299, 301, 326 💬 |
168 |
Interferon gamma 1b |
Interferon Gamma |
- |
- |
- |
228 1件: 228 💬 |
169 |
Interferon gamma-1b |
Interferon Gamma |
1件: D00747 D00747 💬 |
IFNGR1 2件: IFNGR1, IFNGR2 💬 |
Chagas disease 18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
018 7件: 18, 65, 85, 228, 299, 301, 326 💬 |
170 |
Interferon gamma-1b (actimmune) |
Interferon Gamma |
1件: D00747 D00747 💬 |
IFNGR1 2件: IFNGR1, IFNGR2 💬 |
Chagas disease 18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
085 1件: 85 💬 |
171 |
Interferon-gamma |
- |
- |
- |
- |
065 1件: 65 💬 |
172 |
Interferon-gamma 1b |
- |
- |
- |
- |
085 1件: 85 💬 |
173 |
Lentivirus alpha-gal a transduced stem cells |
- |
- |
- |
- |
019 1件: 19 💬 |
174 |
Lingzhi (ganoderma) |
- |
- |
- |
- |
006 1件: 6 💬 |
175 |
Liv-gamma sn inj. |
- |
- |
- |
- |
063 1件: 63 💬 |
176 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
177 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
178 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
179 |
Metalcaptase® 150 mg gastro-resistant tablet |
- |
- |
- |
- |
171 1件: 171 💬 |
180 |
Metalcaptase® 300 mg gastro-resistant tablet |
- |
- |
- |
- |
171 1件: 171 💬 |
181 |
Mezavant gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
182 |
Mezavant xl 1200 mg gastro-resistant prolonged release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
183 |
Mezavant xl 1200 mg gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
184 |
Mezavant xl 1200 mg gastro-resistant, prolonged release tablets. |
- |
- |
- |
- |
097 1件: 97 💬 |
185 |
Mezavant xl 1200mg gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
186 |
Mezavant xl gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
187 |
Moss-agal (recombinant human alpha-galactosidase a produced in moss) |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
188 |
Multi-modal pain management [acetaminophen + gabapentin] |
Acetaminophen |
2件: D00217 D00217, D00332 D00332 💬 |
CACNA2D1 7件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, PTGS1, PTGS2, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 31件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis, Dilated cardiomyopathy, GABAergic synapse, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MAPK signaling pathway, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Synaptic vesicle cycle, TNF signaling pathway, VEGF signaling pathway |
070 1件: 70 💬 |
189 |
Multi-modal pain management [valium + gabapentin] |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 1件: 70 💬 |
190 |
Naglazyme (galsulfase) |
Galsulfase |
1件: D06565 D06565 💬 |
ARSB 1件: ARSB 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |
191 |
Neo-gaa |
- |
- |
- |
- |
256 1件: 256 💬 |
192 |
Noxafil gastro resistant tablets |
- |
- |
- |
- |
060 1件: 60 💬 |
193 |
Obinutuzumab |
Obinutuzumab |
1件: D09321 D09321 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
222 1件: 222 💬 |
194 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (arterial blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 1件: 230 💬 |
195 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (venous blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 1件: 230 💬 |
196 |
Other: computer game based balance and walking rehabilitation for individuals with parkinson's disease |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
197 |
Other: gadobutrol |
Gadobutrol |
1件: D07420 D07420 💬 |
- |
- |
046 1件: 46 💬 |
198 |
Other: gait and balance group training |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
199 |
Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings. |
- |
- |
- |
- |
215 1件: 215 💬 |
200 |
Other: uspio mri - gadolinium mri |
Gadolinium |
- |
- |
- |
013 1件: 13 💬 |
201 |
Ov101 (gaboxadol) |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
206 1件: 206 💬 |
202 |
Pantoprazolo 20 mg gastro-resistant tablets |
- |
- |
- |
- |
065 1件: 65 💬 |
203 |
Perfluorinated gas/oxygen mixture |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
299 1件: 299 💬 |
204 |
Prednisolone 5mg gastro-resistant tablets |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
051 1件: 51 💬 |
205 |
Prefolic*30cpr gastror 15mg |
- |
- |
- |
- |
299 1件: 299 💬 |
206 |
Procedure: gastrointestinal evaluation |
- |
- |
- |
- |
078 1件: 78 💬 |
207 |
Procedure: gastroscopy |
- |
- |
- |
- |
097 1件: 97 💬 |
208 |
Procedure: mri imaging with intravenous contrast with gadoterate meglumine |
Gadoteric acid |
2件: D01796 D01796, D08007 D08007 💬 |
- |
- |
053 1件: 53 💬 |
209 |
Procedure: no gas |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
210 |
Procedure: percutaneous endoscopic gastrostomy with jejunal extension (peg-j) |
- |
- |
- |
- |
006 1件: 6 💬 |
211 |
Procedure: physiotherapy, exercise, percutaneous gastrostomy feeds |
- |
- |
- |
- |
299 1件: 299 💬 |
212 |
Prohance (gadoteridol) |
Gadoteridol |
1件: D01137 D01137 💬 |
- |
- |
013 1件: 13 💬 |
213 |
Raav-gad |
- |
- |
- |
- |
006 1件: 6 💬 |
214 |
Raav1-cmv-gaa (study agent) administration |
- |
- |
- |
- |
256 1件: 256 💬 |
215 |
Raavrh74.mck.galgt2 |
- |
- |
- |
- |
113 1件: 113 💬 |
216 |
Radiation: gadopentetate dimeglumine |
Gadopentetic acid |
2件: D01707 D01707, D08006 D08006 💬 |
- |
- |
013 2件: 13, 34 💬 |
217 |
Recombinant adeno-associated virus 2/6 vector encoding the cdna for human alpha galactosidase a |
- |
- |
- |
- |
019 1件: 19 💬 |
218 |
Recombinant alpha-galactosidase a |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
219 |
Recombinant human alpha-galactosidase |
- |
- |
- |
- |
019 1件: 19 💬 |
220 |
Recombinant human alpha-galactosidase abbreviated as r-h-alpha-gal |
- |
- |
- |
- |
019 1件: 19 💬 |
221 |
Recombinant human growth hormone + rosiglitazone |
Rosiglitazone |
3件: D00596 D00596, D02691 D02691, D08491 D08491 💬 |
GHR 2件: GHR, PPARG 💬 |
AMPK signaling pathway 14件: AMPK signaling pathway, Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Huntington disease, JAK-STAT signaling pathway, Longevity regulating pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
265 1件: 265 💬 |
222 |
Retinoic acid receptor gamma agonist |
Tretinoin |
1件: D00094 D00094 💬 |
PML 3件: PML, RARA, RARB 💬 |
Acute myeloid leukemia 12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
231 1件: 231 💬 |
223 |
Rosiglitazone |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 5件: 46, 75, 97, 222, 265 💬 |
224 |
Rosiglitazone (avandia) |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
222 1件: 222 💬 |
225 |
Rosiglitazone extended release tablets |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 1件: 46 💬 |
226 |
Rosiglitazone maleate |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 3件: 46, 75, 265 💬 |
227 |
Rosiglitazone xr |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 1件: 46 💬 |
228 |
Rs-baclofen |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
010 1件: 10 💬 |
229 |
Salofalk 3g gastro-resistant prolonged-release granules |
- |
- |
- |
- |
097 1件: 97 💬 |
230 |
Salofalk® 500 mg gastro-resistant tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
231 |
Simethicone |
Simethicone |
1件: D05841 D05841 💬 |
- |
- |
013 2件: 13, 96 💬 |
232 |
Sodium valproate 200 mg gastro-resistant tablets |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
233 1件: 233 💬 |
233 |
Sodium valproate wockhardt 200mg gastro-resistant tablets |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
233 1件: 233 💬 |
234 |
Soluble fc-gamma receptor iib |
- |
- |
- |
- |
049 1件: 49 💬 |
235 |
Standard gadolinium contrast |
Gadolinium |
- |
- |
- |
013 1件: 13 💬 |
236 |
Sulfamethoxazole |
Sulfamethoxazole |
1件: D00447 D00447 💬 |
- |
- |
044 4件: 44, 49, 85, 299 💬 |
237 |
Tcm (gan-lu-yin)gly |
- |
- |
- |
- |
053 1件: 53 💬 |
238 |
Teduglutide |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
239 |
Teduglutide (alx-0600) |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
240 |
Teduglutide 0.05 |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
241 |
Teduglutide 0.05 dose |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
242 |
Teduglutide 0.1 mg dose |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
243 |
Teduglutide 0.2 mg |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
244 |
Transdermal fentanyl matrix, gabapentin |
Fentanyl |
3件: D00320 D00320, D00332 D00332, D01399 D01399 💬 |
CACNA2D1 6件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 12件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 1件: 70 💬 |
245 |
Trimethoprim and sulfamethoxazole |
Sulfamethoxazole |
3件: D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 1件: 299 💬 |
246 |
Trimethoprim sulfamethoxazole |
Sulfamethoxazole |
3件: D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
044 1件: 44 💬 |
247 |
Trimethoprim sulfamethoxazole (tmp/smx) |
Sulfamethoxazole |
3件: D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 1件: 299 💬 |
248 |
Trimethoprim-sulfamethoxazole |
Sulfamethoxazole |
3件: D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
049 2件: 49, 299 💬 |
249 |
Trimethoprim/sulfamethoxazole |
Sulfamethoxazole |
3件: D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 1件: 299 💬 |
250 |
Trimethoprim/sulfamethoxazole (tmp/smx) |
Sulfamethoxazole |
3件: D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 1件: 299 💬 |
251 |
Zinc acetate |
Acetate |
1件: D06408 D06408 💬 |
- |
- |
171 2件: 171, 299 💬 |
252 |
Zinc acetate (20mg/d) |
Acetate |
1件: D06408 D06408 💬 |
- |
- |
299 1件: 299 💬 |
253 |
Zinc acetate dihydrate |
Acetate |
1件: D06408 D06408 💬 |
- |
- |
171 1件: 171 💬 |
254 |
Ácido gadobénico |
- |
- |
- |
- |
096 1件: 96 💬 |